7-aminoactinomycin d has been researched along with niacinamide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, YJ; Hsu, ML; Huang, WP; Huang, YC; Ko, WC; Lee, JJ; Lin, JC; Liu, CL; Liu, TP; Wu, CH | 1 |
| Chen, D; Eyupoglu, IY; Savaskan, N | 1 |
2 other study(ies) available for 7-aminoactinomycin d and niacinamide
| Article | Year |
|---|---|
Sorafenib induces autophagy in human myeloid dendritic cells and prolongs survival of skin allografts.
Topics: Animals; Antigens; Autophagy; Cell Survival; Dactinomycin; Dendritic Cells; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Mice; Microscopy, Fluorescence; Myeloid Cells; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Skin Transplantation; Sorafenib; Transplantation, Homologous | 2013 |
Ferroptosis and Cell Death Analysis by Flow Cytometry.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Survival; Dactinomycin; Flow Cytometry; Humans; Indicators and Reagents; Iron; Necrosis; Niacinamide; Phenylurea Compounds; Piperazines; Propidium; Rats; Sorafenib | 2017 |